[1]
S. Y. Kameo, “Hematotoxicity and functional impacts related to chemotherapy with doxorubicin and cyclophosphamide for invasive ductal breast carcinoma: a study in clinical records”, J Health Biol Sci., vol. 9, nº 1, p. 1–8, dez. 2021.